(Total Views: 113)
Posted On: 04/01/2021 8:35:52 AM
Post# of 47159

$KDMN News Article - Kadmon Doses First Patient in Open-Label Phase 2 Clinical Trial of Belumosudil in Systemic Sclerosis https://marketwirenews.com/news-releases/kadm...01580.html


My Twitter: WhyteStocks